相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Synergistic anticancer effects of cisplatin and histone deacetylase inhibitors (SAHA and TSA) on cholangiocarcinoma cell lines
Md. Ali Asgar et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2016)
MiR-509-3-5p causes aberrant mitosis and anti-proliferative effect by suppression of PLK1 in human lung cancer A549 cells
Xian-Hui Wang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2016)
The multidrug transporter ABCG2: still more questions than answers
Aaron J. Horsey et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2016)
A pilot study of concurrent chemoradiotherapy with gemcitabine and cisplatin in patients with locally advanced biliary tract cancer
Kyong Joo Lee et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2016)
The safety profile of vorinostat suberoylanilide hydroxamic acid) in hematologic malignancies: A review of clinical studies
Madeleine Duvic et al.
CANCER TREATMENT REVIEWS (2016)
Overexpression of miR-509 Increases Apoptosis and Inhibits Invasion via Suppression of Tumor Necrosis Factor-α in Triple-Negative Breast Cancer Hs578T Cells
Guoqiang Zhang et al.
ONCOLOGY RESEARCH (2016)
MicroRNA-509-3p increases the sensitivity of epithelial ovarian cancer cells to cisplatin-induced apoptosis
Wei Chen et al.
PHARMACOGENOMICS (2016)
miR-509-3p is clinically significant and strongly attenuates cellular migration and multi-cellular spheroids in ovarian cancer
Yinghong Pan et al.
ONCOTARGET (2016)
First-in-human study of the toxicity, pharmacokinetics, and pharmacodynamics of CG200745, a pan-HDAC inhibitor, in patients with refractory solid malignancies
Kyu-pyo Kim et al.
INVESTIGATIONAL NEW DRUGS (2015)
The microRNA miR-22 inhibits the histone deacetylase HDAC4 to promote TH17 cell-dependent emphysema
Wen Lu et al.
NATURE IMMUNOLOGY (2015)
Class IIa HDACs - new insights into their functions in physiology and pathology
Maribel Parra
FEBS JOURNAL (2015)
Transforming growth factor-β1-induced epithelial-mesenchymal transition generates ALDH-positive cells with stem cell properties in cholangiocarcinoma
Ze-Yu Shuang et al.
CANCER LETTERS (2014)
Pancreatic Cancer hENT1 Expression and Survival From Gemcitabine in Patients From the ESPAC-3 Trial
William Greenhalf et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)
ATP-Binding Cassette Genes Genotype and Expression: A Potential Association with Pancreatic Cancer Development and Chemoresistance?
Li Pang et al.
GASTROENTEROLOGY RESEARCH AND PRACTICE (2014)
Effects of the Hippo Signaling Pathway in Human Gastric Cancer
Guang-Xi Zhou et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2013)
Gas6/Axl mediates tumor cell apoptosis, migration and invasion and predicts the clinical outcome of osteosarcoma. patients
Ju Han et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
Gemcitabine plus Cisplatin versus Capecitabine plus Cisplatin as First-Line Chemotherapy for Advanced Biliary Tract Cancer: A Retrospective Cohort Study
Sang Myung Woo et al.
CHEMOTHERAPY (2013)
Class IIa HDACs repressive activities on MEF2-depedent transcription are associated with poor prognosis of ER+ breast tumors
Andrea Clocchiatti et al.
FASEB JOURNAL (2013)
The Hippo pathway and human cancer
Kieran F. Harvey et al.
NATURE REVIEWS CANCER (2013)
Phase I-II study of vorinostat plus paclitaxel and bevacizumab in metastatic breast cancer: evidence for vorinostat-induced tubulin acetylation and Hsp90 inhibition in vivo
B. Ramaswamy et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Guidelines for the diagnosis and treatment of cholangiocarcinoma: an update
Shahid A. Khan et al.
GUT (2012)
Novel histone deacetylase inhibitor CG200745 induces clonogenic cell death by modulating acetylation of p53 in cancer cells
Eun-Taex Oh et al.
INVESTIGATIONAL NEW DRUGS (2012)
The therapeutic effect of histone deacetylase inhibitor PCI-24781 on gallbladder carcinoma in BK5.erbB2 mice
Takuya Kitamura et al.
JOURNAL OF HEPATOLOGY (2012)
MicroRNA miR-491-5p Targeting both TP53 and Bcl-XL Induces Cell Apoptosis in SW1990 Pancreatic Cancer Cells through Mitochondria Mediated Pathway
Rong Guo et al.
MOLECULES (2012)
Phase I trial of vorinostat combined with bevacizumab and CPT-11 in recurrent glioblastoma
Prakash Chinnaiyan et al.
NEURO-ONCOLOGY (2012)
SAHA Inhibits the Growth of Colon Tumors by Decreasing Histone Deacetylase and the Expression of Cyclin D1 and Survivin
Jong-Shiaw Jin et al.
PATHOLOGY & ONCOLOGY RESEARCH (2012)
Class IIa HDACs: from important roles in differentiation to possible implications in tumourigenesis
Andrea Clocchiatti et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2011)
Effect of histone deacetylase inhibitor in combination with 5-fluorouracil on pancreas cancer and cholangiocarcinoma cell lines
Shuichi Iwahashi et al.
JOURNAL OF MEDICAL INVESTIGATION (2011)
Autophagy potentiates the anti-cancer effects of the histone deacetylase inhibitors in hepatocellular carcinoma
Yuan-Ling Liu et al.
AUTOPHAGY (2010)
ALDHhigh adenoid cystic carcinoma cells display cancer stem cell properties and are responsible for mediating metastasis
Shuyang Sun et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
microRNA-22, downregulated in hepatocellular carcinoma and correlated with prognosis, suppresses cell proliferation and tumourigenicity
J. Zhang et al.
BRITISH JOURNAL OF CANCER (2010)
Gemcitabine alone or in combination with cisplatin in patients with biliary tract cancer: a comparative multicentre study in Japan
T. Okusaka et al.
BRITISH JOURNAL OF CANCER (2010)
Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer.
Juan Valle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
MicroRNAs: Target Recognition and Regulatory Functions
David P. Bartel
CELL (2009)
CD44-positive cells are responsible for gemcitabine resistance in pancreatic cancer cells
Sung Pil Hong et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Effect of histone deacetylase inhibitor on proliferation of biliary tract cancer cell lines
Li-Ning Xu et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2008)
Vorinostat, a histone deacetylase inhibitor, enhances the response of human tumor cells to ionizing radiation through prolongation of γ-H2AX foci
Anupama Munshi et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Rapid alteration of microRNA levels by histone deacetylase inhibition
GK Scott et al.
CANCER RESEARCH (2006)
Selective induction of apoptosis by histone deacetylase inhibitor SAHA in cutaneous T-cell lymphoma cells: Relevance to mechanism of therapeutic action
CL Zhang et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2005)
Drug sensitivity and drug resistance profiles of human intrahepatic cholangiocarcinoma cell lines
Nisana Tepsiri et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2005)
Regulating histone acetyltransferases and deacetylases
G Legube et al.
EMBO REPORTS (2003)
分享论文
